Financial Comparison: Trxade Group (OTCMKTS:TRXD) vs. MultiCell Technologies (OTCMKTS:MEDS)

Trxade Group (OTCMKTS:TRXD) and MultiCell Technologies (NASDAQ:MEDS) are both small-cap retail/wholesale companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations.

Profitability

This table compares Trxade Group and MultiCell Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Trxade Group 0.33% 1.26% 0.61%
MultiCell Technologies -2.82% -4.81% -3.44%

Institutional and Insider Ownership

5.9% of MultiCell Technologies shares are held by institutional investors. 71.3% of Trxade Group shares are held by company insiders. Comparatively, 71.3% of MultiCell Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Volatility & Risk

Trxade Group has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Comparatively, MultiCell Technologies has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for Trxade Group and MultiCell Technologies, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trxade Group 0 0 0 0 N/A
MultiCell Technologies 0 1 1 0 2.50

MultiCell Technologies has a consensus target price of $12.00, indicating a potential upside of 99.67%. Given MultiCell Technologies’ higher possible upside, analysts plainly believe MultiCell Technologies is more favorable than Trxade Group.

Valuation & Earnings

This table compares Trxade Group and MultiCell Technologies’ revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Trxade Group $3.83 million 61.57 $10,000.00 N/A N/A
MultiCell Technologies $7.44 million 6.22 -$280,000.00 $0.03 200.33

Trxade Group has higher earnings, but lower revenue than MultiCell Technologies.

Trxade Group Company Profile

Trxade Group, Inc. owns and operates a business-to-business Web-based marketplace focused on the United States pharmaceutical industry. The company offers Web based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com and InventoryRx.com, which are Web-based pharmaceutical marketplaces; Pharmabayonline that provides access to proprietary pharmaceutical data analytics to the United States-based independent pharmacies, pharmaceutical shortage databases, proposed governmental reimbursement benchmarks comparison and analysis, and a proprietary suggested national retail drug benchmark; and RxGuru, a service-based desktop software application, which provides daily drug pricing and analytics to the independent pharmacists. The company distributes its services through its online platform to independent pharmacies and pharmaceutical suppliers in 18 states of the United States. Trxade Group, Inc. is based in Land O' Lakes, Florida.

MultiCell Technologies Company Profile

Trxade Group, Inc. owns and operates a business-to-business Web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; and Other segments. The company operates a Web based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a Web-based pharmaceutical marketplace; InventoryRx.com, a Web-based pharmaceutical exchange platform; Pharmabayonline that provides proprietary pharmaceutical data analytics and governmental reimbursement benchmarks analysis to the United States-based independent pharmacies and pharmaceutical databases; and RxGuru, a desktop application, which provides product information. The company also operates a retail specialty pharmacy. In addition, it operates Delivmeds.com, a consumer-based app to provide delivery of pharmaceutical products; and Trxademso.com to assist independent retail pharmacies on pricing, distribution, and logistics. Trxade Group, Inc. is based in Land O'Lakes, Florida.

Receive News & Ratings for Trxade Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trxade Group and related companies with MarketBeat.com's FREE daily email newsletter.